197 related articles for article (PubMed ID: 19429701)
1. Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes.
Bimpaki EI; Nesterova M; Stratakis CA
Eur J Endocrinol; 2009 Jul; 161(1):153-61. PubMed ID: 19429701
[TBL] [Abstract][Full Text] [Related]
2. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
[TBL] [Abstract][Full Text] [Related]
3. Targeted Mutational Analysis of Cortisol-Producing Adenomas.
Rege J; Hoxie J; Liu CJ; Cash MN; Luther JM; Gellert L; Turcu AF; Else T; Giordano TJ; Udager AM; Rainey WE; Nanba K
J Clin Endocrinol Metab; 2022 Jan; 107(2):e594-e603. PubMed ID: 34534321
[TBL] [Abstract][Full Text] [Related]
4. Differences in adiposity in Cushing syndrome caused by PRKAR1A mutations: clues for the role of cyclic AMP signaling in obesity and diagnostic implications.
London E; Rothenbuhler A; Lodish M; Gourgari E; Keil M; Lyssikatos C; de la Luz Sierra M; Patronas N; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2014 Feb; 99(2):E303-10. PubMed ID: 24248186
[TBL] [Abstract][Full Text] [Related]
5. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions.
Boikos SA; Horvath A; Heyerdahl S; Stein E; Robinson-White A; Bossis I; Bertherat J; Carney JA; Stratakis CA
Horm Metab Res; 2008 May; 40(5):347-53. PubMed ID: 18491255
[TBL] [Abstract][Full Text] [Related]
7. A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B isoform in human adrenal cortex.
Horvath A; Giatzakis C; Tsang K; Greene E; Osorio P; Boikos S; Libè R; Patronas Y; Robinson-White A; Remmers E; Bertherat J; Nesterova M; Stratakis CA
Eur J Hum Genet; 2008 Oct; 16(10):1245-53. PubMed ID: 18431404
[TBL] [Abstract][Full Text] [Related]
8. Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.
Kool MM; Galac S; Spandauw CG; Kooistra HS; Mol JA
J Vet Intern Med; 2013; 27(6):1486-92. PubMed ID: 24112376
[TBL] [Abstract][Full Text] [Related]
9. How does cAMP/protein kinase A signaling lead to tumors in the adrenal cortex and other tissues?
Almeida MQ; Stratakis CA
Mol Cell Endocrinol; 2011 Apr; 336(1-2):162-8. PubMed ID: 21111774
[TBL] [Abstract][Full Text] [Related]
10. New genes and/or molecular pathways associated with adrenal hyperplasias and related adrenocortical tumors.
Stratakis CA
Mol Cell Endocrinol; 2009 Mar; 300(1-2):152-7. PubMed ID: 19063937
[TBL] [Abstract][Full Text] [Related]
11. GNAS mutations in adrenal aldosterone-producing adenomas.
Nakajima Y; Okamura T; Horiguchi K; Gohko T; Miyamoto T; Satoh T; Ozawa A; Ishii S; Yamada E; Hashimoto K; Okada S; Takata D; Horiguchi J; Yamada M
Endocr J; 2016; 63(2):199-204. PubMed ID: 26743443
[TBL] [Abstract][Full Text] [Related]
12. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
13. Genotype-specific cortisol production associated with Cushing's syndrome adenoma with PRKACA mutations.
Baba R; Oki K; Gomez-Sanchez CE; Otagaki Y; Itcho K; Kobuke K; Kodama T; Nagano G; Ohno H; Yoneda M; Hattori N
Mol Cell Endocrinol; 2021 Dec; 538():111456. PubMed ID: 34520814
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
[TBL] [Abstract][Full Text] [Related]
15. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
[TBL] [Abstract][Full Text] [Related]
16. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.
Horvath A; Boikos S; Giatzakis C; Robinson-White A; Groussin L; Griffin KJ; Stein E; Levine E; Delimpasi G; Hsiao HP; Keil M; Heyerdahl S; Matyakhina L; Libè R; Fratticci A; Kirschner LS; Cramer K; Gaillard RC; Bertagna X; Carney JA; Bertherat J; Bossis I; Stratakis CA
Nat Genet; 2006 Jul; 38(7):794-800. PubMed ID: 16767104
[TBL] [Abstract][Full Text] [Related]
17. PRKAR1A mutations in primary pigmented nodular adrenocortical disease.
Cazabat L; Ragazzon B; Groussin L; Bertherat J
Pituitary; 2006; 9(3):211-9. PubMed ID: 17036196
[TBL] [Abstract][Full Text] [Related]
18. Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype.
Libé R; Horvath A; Vezzosi D; Fratticci A; Coste J; Perlemoine K; Ragazzon B; Guillaud-Bataille M; Groussin L; Clauser E; Raffin-Sanson ML; Siegel J; Moran J; Drori-Herishanu L; Faucz FR; Lodish M; Nesterova M; Bertagna X; Bertherat J; Stratakis CA
J Clin Endocrinol Metab; 2011 Jan; 96(1):E208-14. PubMed ID: 21047926
[TBL] [Abstract][Full Text] [Related]
19. cAMP signaling in cortisol-producing adrenal adenoma.
Calebiro D; Di Dalmazi G; Bathon K; Ronchi CL; Beuschlein F
Eur J Endocrinol; 2015 Oct; 173(4):M99-106. PubMed ID: 26139209
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors.
Libé R; Fratticci A; Coste J; Tissier F; Horvath A; Ragazzon B; Rene-Corail F; Groussin L; Bertagna X; Raffin-Sanson ML; Stratakis CA; Bertherat J
Clin Cancer Res; 2008 Jun; 14(12):4016-24. PubMed ID: 18559625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]